Earnings Analyzer
Stock earnings page

BAUSCH HEALTH COMPANIES INC (BHC)

Track the next or latest earnings date for BAUSCH HEALTH COMPANIES INC, review consensus estimates, and see cached AI analysis for recent quarterly results.

Recent earnings news

Bausch Health (BHC) Rockets 28% as Q2 Turnaround Fuels Recovery Outlook - Insider Monkey
insidermonkey.com · 2026-07-31T04:03:32

READ NEXT: 33 Stocks That Should ... 10 Best Stocks to Buy. Disclosure: None. Follow Insider Monkey on Google News. ... We may use your email to send marketing emails about our services. Click here to read our privacy policy. ... Bausch Health Companies Inc. (NYSE:BHC) Q1 2026 Earnings Call ...

Bausch Health Q2 profit but $1.17B H1 2026 loss | BHC Quarterly Report (10-Q)
stocktitan.net · 2026-07-30T20:11:33

Net loss reached $1.17B on a $1.43B goodwill impairment while Q2 revenue rose to $2.85B and operating cash flow hit $900M; long-term debt totaled $20.24B.

Bausch Health Stock (BHC) Opinions on Q2 2026 Earnings Results | Quiver Quantitative
www.quiverquant.com · 2026-07-30T17:37:27

Q2 Earnings Beat: Social media commentary centered on Bausch Health's solid second-quarter results, where revenue and adjusted earnings exceeded analyst forecasts. The stock climbed sharply following the report, with observers noting accelerated growth in key segments like Salix.

12 Health Care Stocks Moving In Thursday's Intraday Session - Nuwellis (NASDAQ:NUWE), GlucoTrack (NASDAQ: - Benzinga
www.benzinga.com · 2026-07-30T17:05:48

China SXT Pharmaceuticals (NASDAQ:SXTC) stock increased by 29.23% to $0.07. The market value of their outstanding shares is at $2.0 million. Corcept Therapeutics (NASDAQ:CORT) shares moved upwards by 27.53% to $118.55. The company's market cap stands at $9.9 billion. As per the news, the Q2 earnings…

BHC Q2 Earnings Beat Estimates on Salix and Solta Growth, '26 View Raised
ca.finance.yahoo.com · 2026-07-30T16:33:00

Amarin's earnings beat estimates in three of the trailing four quarters and missed in the remaining one, with the average surprise being 50.02%. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report ·…

Latest earnings date

Feb 18, 2026

After-hours

Fiscal quarter: 2025-12-31

EPS estimate: $1.21

Revenue estimate: N/A

Market cap: $2.25B

Analysis snapshot

No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.

Recent earnings history

Browse the calendar week
Date Quarter Report window EPS est. Revenue est.
Feb 18, 2026 2025-12-31 After-hours $1.21 N/A